RWE in Pharma: 5 minutes with…Kathleen Gondek

4 Mar 2022

Written by Kathleen Gondek (Takeda)

COVID-19 Medical devices, pharmaceuticals and vaccines Methodology Real-world evidence RWE in Pharma Stakeholder engagement

In this ‘RWE in Pharma’ interview series, we are putting various pharma experts in the spotlight and asking them to share their insight on how their industry has traditionally employed real-world evidence (RWE), how they envision this changing over the next few years, and what their predictions of the impacts of the highly anticipated U.S. FDA RWE Framework may be. This installment features Kathleen Gondek, Vice President of Global Evidence and Outcomes, and Head of the Real World Data Center of Excellence at Takeda Pharmaceutical Company (Tokyo, Japan). Please could you introduce yourself, your organization(s) and tell us more about...